Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancer
揭示新辅助化疗和内分泌治疗在激素受体阳性/HER2低表达和HER2阴性乳腺癌中引起的临床病理和分子变化
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103619
Schettini, F; Nucera, S; Brasó-Maristany, F; De Santo, I; Pascual, T; Bergamino, M; Galván, P; Conte, B; Seguí, E; García Fructuoso, I; Gómez Bravo, R; Rivera, P; Rodríguez, A B; Martínez-Sáez, O; Ganau, S; Sanfeliu, E; González-Farre, B; Vidal Losada, M J; Adamo, B; Cebrecos, I; Mension, E; Oses, G; Jares, P; Vidal-Sicart, S; Mollà, M; Muñoz, M; Prat, A